VF
PSTV

Virtu Financial’s Plus Therapeutics PSTV Stock Holding History

Virtu Financial’s Portfolio PSTV Stock Details PSTV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,870
Closed -$254K – 2165
2025
Q4 		$254K Buy
+19,870
New +$300K 0.01% 925
2025
Q2 		– Sell
-1,601
Closed -$38K – 1935
2025
Q1 		$38K Buy
+1,601
New +$44.8K ﹤0.01% 1044
2023
Q1 		– Sell
-36
Closed -$4K – 1976
2022
Q4 		$4K Buy
+36
New +$5.73K ﹤0.01% 1456
2021
Q3 		– Sell
-203
Closed -$195K – 1865
2021
Q2 		$195K Buy
+203
New +$183K 0.02% 1008
2021
Q1 		– Sell
-49
Closed -$37K – 1928
2020
Q4 		$37K Sell
49
-9
-16% -$7.7K ﹤0.01% 1279
2020
Q3 		$56K Buy
+58
New +$56.2K 0.01% 809
2019
Q4 		$35K Buy
+39
New +$35.7K ﹤0.01% 1257
2019
Q2 		– Sell
-8
Closed -$36K – 1770
2019
Q1 		$36K Buy
8
+6
+300% +$31.7K ﹤0.01% 1246
2018
Q4 		$12K Buy
+2
New +$13.2K ﹤0.01% 1425
2018
Q3 		– Sell
-1
Closed -$34K – 2051
2018
Q2 		$34K Hold
1
– – ﹤0.01% 1813
2018
Q1 		$41K Buy
+1
New +$65.7K ﹤0.01% 1744
2017
Q4 		– Hold
0
– -$10K – 2868
2017
Q3 		– Hold
0
– – – 2409

Other funds holding PSTV

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Virtu Financial's PSTV Position: Q1 2026 in Review

Virtu Financial sold out of Plus Therapeutics (PSTV) in Q1 2026, closing a stake of 19,870 shares — an estimated $254K sold.

Virtu Financial first reported a position in PSTV in Q1 2018 and held it in 11 quarters. The position peaked at $254K in Q4 2025. 23 funds tracked by Wall St. Rank hold PSTV as of Q1 2026.

  • Virtu Financial reported no remaining Plus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 19,870 Plus Therapeutics shares in Q1 2026, an estimated $254K.
  • Virtu Financial first reported a position in Plus Therapeutics in Q1 2018 and held it in 11 quarters.
  • Virtu Financial's Plus Therapeutics position peaked at $254K in Q4 2025.
  • 23 funds tracked by Wall St. Rank held Plus Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.